 Hypoglycemia
"Hypoglycemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Descriptor ID |
D007003
|
| MeSH Number(s) |
C18.452.394.984
|
| Concept/Terms |
Fasting Hypoglycemia- Fasting Hypoglycemia
- Hypoglycemia, Fasting
- Postabsorptive Hypoglycemia
- Hypoglycemia, Postabsorptive
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemia".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemia".
This graph shows the total number of publications written about "Hypoglycemia" by people in this website by year, and whether "Hypoglycemia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 2 | 6 | | 2004 | 5 | 4 | 9 | | 2005 | 2 | 2 | 4 | | 2006 | 4 | 1 | 5 | | 2007 | 6 | 5 | 11 | | 2008 | 3 | 3 | 6 | | 2009 | 4 | 5 | 9 | | 2010 | 8 | 1 | 9 | | 2011 | 3 | 2 | 5 | | 2012 | 6 | 0 | 6 | | 2013 | 8 | 5 | 13 | | 2014 | 15 | 3 | 18 | | 2015 | 13 | 5 | 18 | | 2016 | 10 | 5 | 15 | | 2017 | 20 | 11 | 31 | | 2018 | 9 | 10 | 19 | | 2019 | 10 | 7 | 17 | | 2020 | 9 | 10 | 19 | | 2021 | 5 | 1 | 6 | | 2022 | 22 | 0 | 22 | | 2023 | 15 | 1 | 16 | | 2024 | 13 | 10 | 23 | | 2025 | 4 | 6 | 10 | | 2026 | 6 | 7 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoglycemia" by people in Profiles.
-
Jacobsen LM, Cuthbertson D, Felton J, Sherr JL, Simmons KM, Hosford J, Ismail HM, Greenbaum CJ, Wherrett DK, Pinckney A, Sanda S, DiMeglio LA, Higdon LE, Evans-Molina C. Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile. Diabetes Care. 2026 Aug 01; 49(8):1428-1433.
-
Cook TM, Bethea M, da Silva Teixeira S, Birznieks C, McClennan A, Hendrix J, Benninger RK, Patti ME, Sandoval DA. Dysregulated glucagon signaling contributes to hypoglycemia after vertical sleeve gastrectomy in mice. Mol Metab. 2026 Aug; 110:102399.
-
Sinha R, Uz Zaman S, Mohamed RC, Singh A, Saxena D, Pati AK. Efficacy and Safety of Inhalational Insulin Compared With Rapid-Acting Insulin Analogs: A Systematic Review and Meta-Analysis. Clin Ther. 2026 Aug; 48(8):790-797.
-
Al Rawashdh N, Patel BV, Wang SM, Zur RM, Anaya P, Kahn EB, Pinsker JE, Sasson-Katchalski R, Trahan AC, Messer LH, Assadi K, Kudva YC, Beck RW. Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Diabetes Obes Metab. 2026 Jul; 28(7):6280-6290.
-
Connery L, Rosenstock J, Rasouli N, Cheng AYY, Liebl A, Wang Q, Pires V, Knights A, Davidson MB, Child CJ. Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes. Diabetes Obes Metab. 2026 Jul; 28(7):6217-6224.
-
Zhao W, Chrisenberry DB, Varela M, Luna-Ramirez RI, Anderson MJ, Langlais PR, Brown LD, Limesand SW. Correction of hypoxemia and hypoglycemia restores muscle mitochondrial respiration and remodels mitochondrial proteome in growth-restricted sheep fetuses. Am J Physiol Endocrinol Metab. 2026 Jun 01; 330(6):E774-E781.
-
Driscoll KA, Trojanowski PJ, Shaffer ER, Manis H, Pardon A, Reynolds CM, Wetter-Wren SE, O'Donnell HK, Patton SR. A Review of the Fear of Hypoglycemia Literature in Children and Adolescents with Type 1 Diabetes and their Caregivers. Curr Diab Rep. 2026 Mar 23; 26(1).
-
Akturk HK, Karakus KE, Chen B, Walker TC. Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar; 28(3):264-270.
-
Akturk HK, Mason E, Cengiz D, Karakus KE, Garg SK. Patient-Reported Adverse Events with Adjunctive Tirzepatide or Semaglutide Treatment in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2026 Jun; 28(6):614-618.
-
Ferraz-Bannitz R, Pei L, Wang H, Ozturk B, Casanova Querol P, Gonçalves da Cruz A, Cook TM, Saeed H, Osterwalder L, Poulos L, Saifeldin H, Cummings C, Farahmandsadr M, Amore A, Sheehan A, Simonson DC, Sandoval DA, Patti ME. Plasma GDF15 increases during hyperinsulinemic hypoglycemia in humans with post-bariatric hypoglycemia and after insulin exposure in mice. Cell Rep Med. 2026 Mar 17; 7(3):102656.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|